

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.82539989 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.82539989 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.71316146 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.71316146 |
| 5 | lysine catabolic process (GO:0006554) | 6.44526091 |
| 6 | lysine metabolic process (GO:0006553) | 6.44526091 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.42163755 |
| 8 | glyoxylate metabolic process (GO:0046487) | 6.35951751 |
| 9 | cobalamin metabolic process (GO:0009235) | 6.29274544 |
| 10 | drug transmembrane transport (GO:0006855) | 6.27694386 |
| 11 | cysteine metabolic process (GO:0006534) | 6.26365328 |
| 12 | urate metabolic process (GO:0046415) | 6.20427229 |
| 13 | digestion (GO:0007586) | 6.11776888 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.02243688 |
| 15 | tryptophan catabolic process (GO:0006569) | 6.02243688 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 6.02243688 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.67220201 |
| 18 | kynurenine metabolic process (GO:0070189) | 5.63802989 |
| 19 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.47644897 |
| 20 | homocysteine metabolic process (GO:0050667) | 5.37924920 |
| 21 | drug transport (GO:0015893) | 5.29798885 |
| 22 | drug catabolic process (GO:0042737) | 5.22946444 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.18333369 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.12188023 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.10097861 |
| 26 | bile acid biosynthetic process (GO:0006699) | 4.94369727 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 4.88760967 |
| 28 | sodium-independent organic anion transport (GO:0043252) | 4.83297759 |
| 29 | actin filament depolymerization (GO:0030042) | 4.80682019 |
| 30 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.74219100 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.71737433 |
| 32 | urea metabolic process (GO:0019627) | 4.64386898 |
| 33 | urea cycle (GO:0000050) | 4.64386898 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 4.62591782 |
| 35 | intestinal absorption (GO:0050892) | 4.62509565 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 4.59142095 |
| 37 | complement activation, classical pathway (GO:0006958) | 4.57700097 |
| 38 | exogenous drug catabolic process (GO:0042738) | 4.57458212 |
| 39 | short-chain fatty acid metabolic process (GO:0046459) | 4.53985423 |
| 40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.53523084 |
| 41 | serine family amino acid metabolic process (GO:0009069) | 4.53154604 |
| 42 | aspartate family amino acid catabolic process (GO:0009068) | 4.49756563 |
| 43 | cellular modified amino acid catabolic process (GO:0042219) | 4.47062915 |
| 44 | response to hepatocyte growth factor (GO:0035728) | 4.44898933 |
| 45 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.44898933 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.42691722 |
| 47 | glutamate metabolic process (GO:0006536) | 4.41194198 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 4.30858914 |
| 49 | acute-phase response (GO:0006953) | 4.27697119 |
| 50 | bile acid metabolic process (GO:0008206) | 4.26987470 |
| 51 | response to mercury ion (GO:0046689) | 4.26886328 |
| 52 | phosphate ion transport (GO:0006817) | 4.24629894 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.23834964 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.23588094 |
| 55 | regulation of cellular extravasation (GO:0002691) | 4.16456180 |
| 56 | * calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.13261063 |
| 57 | intestinal cholesterol absorption (GO:0030299) | 4.12309513 |
| 58 | epithelial structure maintenance (GO:0010669) | 4.09734274 |
| 59 | benzene-containing compound metabolic process (GO:0042537) | 4.08228526 |
| 60 | organic cation transport (GO:0015695) | 4.07776638 |
| 61 | serine family amino acid biosynthetic process (GO:0009070) | 4.07635498 |
| 62 | daunorubicin metabolic process (GO:0044597) | 4.07370729 |
| 63 | polyketide metabolic process (GO:0030638) | 4.07370729 |
| 64 | doxorubicin metabolic process (GO:0044598) | 4.07370729 |
| 65 | acetyl-CoA metabolic process (GO:0006084) | 4.05782080 |
| 66 | 2-oxoglutarate metabolic process (GO:0006103) | 4.05676674 |
| 67 | amine catabolic process (GO:0009310) | 4.02966903 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.02966903 |
| 69 | phosphate ion transmembrane transport (GO:0035435) | 4.02517664 |
| 70 | lung vasculature development (GO:0060426) | 4.01856503 |
| 71 | cellular glucuronidation (GO:0052695) | 4.01116910 |
| 72 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.99715638 |
| 73 | opsonization (GO:0008228) | 3.98823305 |
| 74 | tyrosine metabolic process (GO:0006570) | 3.98419188 |
| 75 | fatty acid beta-oxidation (GO:0006635) | 3.97712962 |
| 76 | ketone body metabolic process (GO:1902224) | 3.96272913 |
| 77 | peptide catabolic process (GO:0043171) | 3.95431921 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 3.93546523 |
| 79 | transepithelial transport (GO:0070633) | 3.92567152 |
| 80 | epoxygenase P450 pathway (GO:0019373) | 3.89873418 |
| 81 | fatty acid oxidation (GO:0019395) | 3.88629033 |
| 82 | complement activation (GO:0006956) | 3.88162629 |
| 83 | carnitine metabolic process (GO:0009437) | 3.88058918 |
| 84 | high-density lipoprotein particle remodeling (GO:0034375) | 3.87599251 |
| 85 | icosanoid transport (GO:0071715) | 3.87131014 |
| 86 | fatty acid derivative transport (GO:1901571) | 3.87131014 |
| 87 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.85921537 |
| 88 | regulation of apoptotic cell clearance (GO:2000425) | 3.85319472 |
| 89 | negative regulation of cholesterol transport (GO:0032375) | 3.83510146 |
| 90 | negative regulation of sterol transport (GO:0032372) | 3.83510146 |
| 91 | protein carboxylation (GO:0018214) | 3.83125712 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.83125712 |
| 93 | lipid oxidation (GO:0034440) | 3.80819767 |
| 94 | angiotensin maturation (GO:0002003) | 3.80120851 |
| 95 | complement activation, alternative pathway (GO:0006957) | 3.79455635 |
| 96 | negative regulation of fibrinolysis (GO:0051918) | 3.79168894 |
| 97 | aldehyde catabolic process (GO:0046185) | 3.79128159 |
| 98 | glycine metabolic process (GO:0006544) | 3.78946299 |
| 99 | ethanol oxidation (GO:0006069) | 3.78687775 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.78661981 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.78661981 |
| 102 | organic acid catabolic process (GO:0016054) | 3.78349005 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.78349005 |
| 104 | bile acid and bile salt transport (GO:0015721) | 3.78001137 |
| 105 | acute inflammatory response (GO:0002526) | 3.77073734 |
| 106 | valine metabolic process (GO:0006573) | 3.73057449 |
| 107 | flavonoid metabolic process (GO:0009812) | 3.72686899 |
| 108 | regulation of protein activation cascade (GO:2000257) | 3.71518097 |
| 109 | regulation of triglyceride catabolic process (GO:0010896) | 3.71404078 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.71140498 |
| 111 | quaternary ammonium group transport (GO:0015697) | 3.67576202 |
| 112 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67491099 |
| 113 | acylglycerol homeostasis (GO:0055090) | 3.67481390 |
| 114 | triglyceride homeostasis (GO:0070328) | 3.67481390 |
| 115 | reverse cholesterol transport (GO:0043691) | 3.64691631 |
| 116 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.64411262 |
| 117 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.64411262 |
| 118 | vitamin D metabolic process (GO:0042359) | 3.63331893 |
| 119 | fatty acid catabolic process (GO:0009062) | 3.61824207 |
| 120 | monocarboxylic acid catabolic process (GO:0072329) | 3.61289412 |
| 121 | tricarboxylic acid metabolic process (GO:0072350) | 3.61010326 |
| 122 | drug metabolic process (GO:0017144) | 3.59321400 |
| 123 | fructose metabolic process (GO:0006000) | 3.55266086 |
| 124 | regulation of fibrinolysis (GO:0051917) | 3.54895291 |
| 125 | coenzyme catabolic process (GO:0009109) | 3.54763072 |
| 126 | regulation of interleukin-8 secretion (GO:2000482) | 3.53829327 |
| 127 | primary alcohol catabolic process (GO:0034310) | 3.53621119 |
| 128 | branched-chain amino acid metabolic process (GO:0009081) | 3.52827183 |
| 129 | regulation of cholesterol esterification (GO:0010872) | 3.52650094 |
| 130 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.51178889 |
| 131 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.48284986 |
| 132 | regulation of complement activation (GO:0030449) | 3.46769100 |
| 133 | response to nitrosative stress (GO:0051409) | 3.45178335 |
| 134 | auditory receptor cell differentiation (GO:0042491) | 3.44561817 |
| 135 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.38637986 |
| 136 | protein-lipid complex remodeling (GO:0034368) | 3.38354836 |
| 137 | macromolecular complex remodeling (GO:0034367) | 3.38354836 |
| 138 | plasma lipoprotein particle remodeling (GO:0034369) | 3.38354836 |
| 139 | renal absorption (GO:0070293) | 3.35514748 |
| 140 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.29907774 |
| 141 | excretion (GO:0007588) | 3.29710138 |
| 142 | protein activation cascade (GO:0072376) | 3.28826558 |
| 143 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.25504913 |
| 144 | lung lobe morphogenesis (GO:0060463) | 3.17225668 |
| 145 | renal filtration (GO:0097205) | 3.07150752 |
| 146 | antibacterial humoral response (GO:0019731) | 3.00118995 |
| 147 | digestive system process (GO:0022600) | 2.97809367 |
| 148 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.95817061 |
| 149 | regulation of macrophage chemotaxis (GO:0010758) | 2.93187526 |
| 150 | glomerular filtration (GO:0003094) | 2.92002388 |
| 151 | glycoside metabolic process (GO:0016137) | 2.91587901 |
| 152 | glutathione biosynthetic process (GO:0006750) | 2.91048613 |
| 153 | antimicrobial humoral response (GO:0019730) | 2.86377939 |
| 154 | cholesterol homeostasis (GO:0042632) | 2.86191709 |
| 155 | desmosome organization (GO:0002934) | 2.85230651 |
| 156 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.84073449 |
| 157 | regulation of metalloenzyme activity (GO:0048552) | 2.83487393 |
| 158 | hormone catabolic process (GO:0042447) | 2.82353807 |
| 159 | sterol homeostasis (GO:0055092) | 2.81870963 |
| 160 | positive regulation of respiratory burst (GO:0060267) | 2.79349753 |
| 161 | L-ascorbic acid metabolic process (GO:0019852) | 2.78295284 |
| 162 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.77741091 |
| 163 | nephron tubule formation (GO:0072079) | 2.76382308 |
| 164 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.75929125 |
| 165 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.75350728 |
| 166 | thyroid hormone generation (GO:0006590) | 2.74595491 |
| 167 | phenylpropanoid metabolic process (GO:0009698) | 2.74329452 |
| 168 | O-glycan processing (GO:0016266) | 2.73975215 |
| 169 | toxin transport (GO:1901998) | 2.73151914 |
| 170 | positive regulation of metanephros development (GO:0072216) | 2.71524415 |
| 171 | cellular response to vitamin D (GO:0071305) | 2.71407793 |
| 172 | positive regulation of glomerulus development (GO:0090193) | 2.70532973 |
| 173 | ethanol metabolic process (GO:0006067) | 2.70153046 |
| 174 | hydrogen peroxide metabolic process (GO:0042743) | 2.60208626 |
| 175 | metanephric nephron epithelium development (GO:0072243) | 2.59301369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.60023633 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.64575373 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.89780042 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.58308670 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.87737157 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.24472519 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.90310786 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.63149504 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.18098041 |
| 10 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.68295283 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.38483838 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.32686993 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.31879400 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27038010 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10922698 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07580900 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4348208 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.84125373 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.83236525 |
| 20 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.78537362 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72185214 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70394119 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66242370 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64977642 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.64797371 |
| 26 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.64621261 |
| 27 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.63340215 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59012166 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51953831 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49216749 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44899338 |
| 32 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32248603 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31530026 |
| 34 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.29720788 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26238697 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24005194 |
| 37 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.22616403 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22593008 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20915925 |
| 40 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17805759 |
| 41 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17805759 |
| 42 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.16659036 |
| 43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14542509 |
| 44 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13514681 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12525637 |
| 46 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11491374 |
| 47 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10480435 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09594668 |
| 49 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08562759 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07872233 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07439789 |
| 52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03407445 |
| 53 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.03212985 |
| 54 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99700977 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99036655 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97559913 |
| 57 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95958465 |
| 58 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95713258 |
| 59 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95508190 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94846575 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94672772 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94639547 |
| 63 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90299938 |
| 64 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89450590 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88476348 |
| 66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88006398 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86867550 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86835540 |
| 69 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86059649 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85694666 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84474892 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83281696 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82687140 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82059214 |
| 75 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81843839 |
| 76 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81801859 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81210224 |
| 78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81051650 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80646714 |
| 80 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.80604993 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79330917 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78921743 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77591601 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.76886101 |
| 85 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76620508 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76439257 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76373523 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75927039 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75927039 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74046476 |
| 91 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.73595544 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73261114 |
| 93 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.72913372 |
| 94 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72691085 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.72263402 |
| 96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70464517 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.70405180 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.70145131 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68795230 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.68369256 |
| 101 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.67802556 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.66797179 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.66258706 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65567061 |
| 105 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.65557575 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65438699 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65316861 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.64968610 |
| 109 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64735474 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.63964750 |
| 111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.63377148 |
| 112 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62753691 |
| 113 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.61947008 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61619752 |
| 115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.61369280 |
| 116 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.61342450 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.61171468 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60641233 |
| 119 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60409287 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60129103 |
| 121 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59824956 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.58646417 |
| 123 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.58432675 |
| 124 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.58218479 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56639620 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.56555136 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.56385212 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.56015875 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55482426 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.52030276 |
| 131 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.51824022 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51228479 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.50166347 |
| 134 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.50166347 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.49671521 |
| 136 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.49372457 |
| 137 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.48527604 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.47647749 |
| 139 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.47644891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.36396517 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.43270781 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.26952768 |
| 4 | MP0005365_abnormal_bile_salt | 5.08201910 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.46002670 |
| 6 | MP0003252_abnormal_bile_duct | 3.90032924 |
| 7 | MP0005332_abnormal_amino_acid | 3.68634615 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.64660809 |
| 9 | MP0003195_calcinosis | 3.44677184 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.19488144 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.10777860 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.93820837 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.73060379 |
| 14 | MP0005409_darkened_coat_color | 2.71161776 |
| 15 | MP0004043_abnormal_pH_regulation | 2.65959364 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.61223506 |
| 17 | * MP0009643_abnormal_urine_homeostasis | 2.40632306 |
| 18 | MP0009840_abnormal_foam_cell | 2.29318618 |
| 19 | MP0003866_abnormal_defecation | 2.18624145 |
| 20 | MP0005083_abnormal_biliary_tract | 2.08857065 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.08249643 |
| 22 | MP0005636_abnormal_mineral_homeostasis | 1.93511648 |
| 23 | MP0005023_abnormal_wound_healing | 1.83454010 |
| 24 | MP0001664_abnormal_digestion | 1.83321652 |
| 25 | MP0001873_stomach_inflammation | 1.80326414 |
| 26 | MP0000609_abnormal_liver_physiology | 1.72252607 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.72028004 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.71461101 |
| 29 | MP0001765_abnormal_ion_homeostasis | 1.69476058 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61880031 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.52516606 |
| 32 | * MP0002136_abnormal_kidney_physiology | 1.48677772 |
| 33 | * MP0001756_abnormal_urination | 1.46767494 |
| 34 | MP0003186_abnormal_redox_activity | 1.45836452 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.43883815 |
| 36 | MP0001764_abnormal_homeostasis | 1.38978770 |
| 37 | MP0005451_abnormal_body_composition | 1.36705524 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.35106476 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.34823618 |
| 40 | MP0004272_abnormal_basement_membrane | 1.34005059 |
| 41 | MP0003868_abnormal_feces_composition | 1.29551348 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.24440310 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.20476005 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.18695194 |
| 45 | MP0002132_abnormal_respiratory_system | 1.16286313 |
| 46 | MP0003136_yellow_coat_color | 1.12634052 |
| 47 | MP0002928_abnormal_bile_duct | 1.06523113 |
| 48 | MP0000477_abnormal_intestine_morphology | 1.04324718 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.03480526 |
| 50 | MP0002089_abnormal_postnatal_growth/wei | 1.03103417 |
| 51 | MP0000490_abnormal_crypts_of | 1.02567515 |
| 52 | MP0001188_hyperpigmentation | 1.00629588 |
| 53 | MP0000598_abnormal_liver_morphology | 0.98034726 |
| 54 | MP0000538_abnormal_urinary_bladder | 0.97312189 |
| 55 | MP0009764_decreased_sensitivity_to | 0.96257446 |
| 56 | MP0005058_abnormal_lysosome_morphology | 0.95093964 |
| 57 | MP0003045_fibrosis | 0.94885420 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 0.93801027 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 0.92272474 |
| 60 | MP0004858_abnormal_nervous_system | 0.91962505 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 0.91943016 |
| 62 | MP0009785_altered_susceptibility_to | 0.90434186 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 0.89822129 |
| 64 | MP0003878_abnormal_ear_physiology | 0.89822129 |
| 65 | MP0003879_abnormal_hair_cell | 0.89401882 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 0.88302291 |
| 67 | MP0009642_abnormal_blood_homeostasis | 0.87043370 |
| 68 | MP0003011_delayed_dark_adaptation | 0.86720767 |
| 69 | MP0004233_abnormal_muscle_weight | 0.84217851 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 0.83999825 |
| 71 | MP0001881_abnormal_mammary_gland | 0.82599809 |
| 72 | MP0005408_hypopigmentation | 0.81768448 |
| 73 | MP0000604_amyloidosis | 0.80177704 |
| 74 | MP0008469_abnormal_protein_level | 0.80162377 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.78804591 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.78319046 |
| 77 | MP0008004_abnormal_stomach_pH | 0.75878168 |
| 78 | MP0002168_other_aberrant_phenotype | 0.73136058 |
| 79 | MP0000249_abnormal_blood_vessel | 0.72994941 |
| 80 | MP0001485_abnormal_pinna_reflex | 0.71051294 |
| 81 | MP0005670_abnormal_white_adipose | 0.70026128 |
| 82 | MP0002796_impaired_skin_barrier | 0.69814176 |
| 83 | MP0010678_abnormal_skin_adnexa | 0.69179347 |
| 84 | MP0005535_abnormal_body_temperature | 0.68044718 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.67987256 |
| 86 | MP0001661_extended_life_span | 0.67733603 |
| 87 | MP0001958_emphysema | 0.66424330 |
| 88 | MP0009763_increased_sensitivity_to | 0.66410533 |
| 89 | MP0003329_amyloid_beta_deposits | 0.65850937 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.64810237 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.64778824 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.64140012 |
| 93 | MP0005395_other_phenotype | 0.63979113 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.63742649 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.63313175 |
| 96 | MP0004147_increased_porphyrin_level | 0.62919071 |
| 97 | MP0003943_abnormal_hepatobiliary_system | 0.62660563 |
| 98 | MP0005647_abnormal_sex_gland | 0.62356194 |
| 99 | MP0005448_abnormal_energy_balance | 0.61150341 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.60581244 |
| 101 | MP0002135_abnormal_kidney_morphology | 0.59949398 |
| 102 | MP0002166_altered_tumor_susceptibility | 0.59597251 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.58934373 |
| 104 | MP0009697_abnormal_copulation | 0.57996762 |
| 105 | MP0002254_reproductive_system_inflammat | 0.57626184 |
| 106 | MP0003436_decreased_susceptibility_to | 0.55464846 |
| 107 | MP0002971_abnormal_brown_adipose | 0.52245505 |
| 108 | MP0006138_congestive_heart_failure | 0.51052812 |
| 109 | MP0009053_abnormal_anal_canal | 0.50282984 |
| 110 | MP0005025_abnormal_response_to | 0.49749093 |
| 111 | MP0005166_decreased_susceptibility_to | 0.49254921 |
| 112 | MP0004947_skin_inflammation | 0.48679502 |
| 113 | MP0005164_abnormal_response_to | 0.48520798 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.48308450 |
| 115 | MP0000534_abnormal_ureter_morphology | 0.48150493 |
| 116 | MP0002163_abnormal_gland_morphology | 0.48008035 |
| 117 | MP0001663_abnormal_digestive_system | 0.47837050 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.47591322 |
| 119 | MP0000343_altered_response_to | 0.47364453 |
| 120 | MP0000627_abnormal_mammary_gland | 0.45790747 |
| 121 | MP0008872_abnormal_physiological_respon | 0.44736164 |
| 122 | MP0001944_abnormal_pancreas_morphology | 0.44507056 |
| 123 | MP0003953_abnormal_hormone_level | 0.42949332 |
| 124 | MP0005334_abnormal_fat_pad | 0.42861822 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.42239808 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.41629297 |
| 127 | MP0005266_abnormal_metabolism | 0.41594069 |
| 128 | MP0005501_abnormal_skin_physiology | 0.38717566 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.38604156 |
| 130 | MP0003724_increased_susceptibility_to | 0.37717774 |
| 131 | MP0000462_abnormal_digestive_system | 0.35158774 |
| 132 | MP0002098_abnormal_vibrissa_morphology | 0.34675731 |
| 133 | MP0010368_abnormal_lymphatic_system | 0.34519486 |
| 134 | MP0008873_increased_physiological_sensi | 0.34399903 |
| 135 | MP0005165_increased_susceptibility_to | 0.34195029 |
| 136 | MP0003959_abnormal_lean_body | 0.34010861 |
| 137 | MP0001845_abnormal_inflammatory_respons | 0.33554999 |
| 138 | MP0003075_altered_response_to | 0.32487663 |
| 139 | MP0010155_abnormal_intestine_physiology | 0.31864934 |
| 140 | MP0003690_abnormal_glial_cell | 0.31771011 |
| 141 | MP0004130_abnormal_muscle_cell | 0.31715104 |
| 142 | MP0003718_maternal_effect | 0.30542030 |
| 143 | MP0004885_abnormal_endolymph | 0.30113295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exocrine pancreatic insufficiency (HP:0001738) | 5.66795834 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.52069397 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.45939103 |
| 4 | Gout (HP:0001997) | 5.42195852 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.21978154 |
| 6 | Hyperglycinuria (HP:0003108) | 4.95477869 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.79477653 |
| 8 | Xanthomatosis (HP:0000991) | 4.57913334 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.52834733 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.45861460 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.45861460 |
| 12 | Cerebral palsy (HP:0100021) | 4.35217453 |
| 13 | Abnormality of purine metabolism (HP:0004352) | 4.27581421 |
| 14 | Ketosis (HP:0001946) | 4.23155131 |
| 15 | Hyperammonemia (HP:0001987) | 4.18464312 |
| 16 | Growth hormone excess (HP:0000845) | 4.13551781 |
| 17 | Proximal tubulopathy (HP:0000114) | 4.12974325 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 4.12312341 |
| 19 | Potter facies (HP:0002009) | 4.11629581 |
| 20 | Facial shape deformation (HP:0011334) | 4.11629581 |
| 21 | Hyperglycinemia (HP:0002154) | 4.06960796 |
| 22 | Increased circulating renin level (HP:0000848) | 4.06836878 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06110686 |
| 24 | Increased purine levels (HP:0004368) | 4.04457057 |
| 25 | Hyperuricemia (HP:0002149) | 4.04457057 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 4.02587036 |
| 27 | Hypokalemic alkalosis (HP:0001949) | 4.00883329 |
| 28 | Hyperactive renin-angiotensin system (HP:0000841) | 3.99979956 |
| 29 | Metabolic alkalosis (HP:0200114) | 3.96808544 |
| 30 | Ketoacidosis (HP:0001993) | 3.86302460 |
| 31 | Glomerulonephritis (HP:0000099) | 3.81323564 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.78782482 |
| 33 | Alkalosis (HP:0001948) | 3.75758384 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.74634299 |
| 35 | Abnormality of chloride homeostasis (HP:0011422) | 3.65755898 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61917547 |
| 37 | Neonatal death (HP:0003811) | 3.55373139 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 3.54693827 |
| 39 | Abnormal urine output (HP:0012590) | 3.49452422 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 3.45794794 |
| 41 | Polyuria (HP:0000103) | 3.44386492 |
| 42 | Hypomagnesemia (HP:0002917) | 3.43393349 |
| 43 | Abnormality of renal excretion (HP:0011036) | 3.38088270 |
| 44 | Generalized aminoaciduria (HP:0002909) | 3.33277399 |
| 45 | Hypoglycemic coma (HP:0001325) | 3.26777285 |
| 46 | Focal segmental glomerulosclerosis (HP:0000097) | 3.26325195 |
| 47 | Complement deficiency (HP:0004431) | 3.23759808 |
| 48 | Vascular calcification (HP:0004934) | 3.23738325 |
| 49 | Glycosuria (HP:0003076) | 3.23440621 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 3.23440621 |
| 51 | Delayed CNS myelination (HP:0002188) | 3.18590854 |
| 52 | Fat malabsorption (HP:0002630) | 3.18076895 |
| 53 | Seborrheic dermatitis (HP:0001051) | 3.16375439 |
| 54 | Severe visual impairment (HP:0001141) | 3.15371665 |
| 55 | Arterial tortuosity (HP:0005116) | 3.14553311 |
| 56 | Glomerulosclerosis (HP:0000096) | 3.14014692 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 3.13960276 |
| 58 | Goiter (HP:0000853) | 3.13667389 |
| 59 | Rectal prolapse (HP:0002035) | 3.10632109 |
| 60 | Nephritis (HP:0000123) | 3.08064097 |
| 61 | Malnutrition (HP:0004395) | 3.07529335 |
| 62 | Abnormality of proline metabolism (HP:0010907) | 3.03564441 |
| 63 | Hydroxyprolinuria (HP:0003080) | 3.03564441 |
| 64 | Hypolipoproteinemia (HP:0010981) | 3.00092465 |
| 65 | Abnormality of macular pigmentation (HP:0008002) | 2.99136342 |
| 66 | Abnormality of the gastric mucosa (HP:0004295) | 2.98241121 |
| 67 | Abnormality of magnesium homeostasis (HP:0004921) | 2.94855951 |
| 68 | Metabolic acidosis (HP:0001942) | 2.94743927 |
| 69 | Joint hemorrhage (HP:0005261) | 2.92124474 |
| 70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90156064 |
| 71 | Congenital sensorineural hearing impairment (HP:0008527) | 2.89290163 |
| 72 | Hypoproteinemia (HP:0003075) | 2.88102024 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.87190904 |
| 74 | Epidermoid cyst (HP:0200040) | 2.86382950 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 2.84091687 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.84091687 |
| 77 | Lethargy (HP:0001254) | 2.77332082 |
| 78 | Tubulointerstitial fibrosis (HP:0005576) | 2.77201274 |
| 79 | Scotoma (HP:0000575) | 2.76886126 |
| 80 | Abnormality of the common coagulation pathway (HP:0010990) | 2.75643676 |
| 81 | Vascular tortuosity (HP:0004948) | 2.72045414 |
| 82 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.68740056 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.68530156 |
| 84 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.67535773 |
| 85 | Abnormality of methionine metabolism (HP:0010901) | 2.64554127 |
| 86 | Rickets (HP:0002748) | 2.64344250 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 2.63815257 |
| 88 | Joint swelling (HP:0001386) | 2.55786536 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 2.55617796 |
| 90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.54528650 |
| 91 | Nephrolithiasis (HP:0000787) | 2.53562249 |
| 92 | Hyperphosphaturia (HP:0003109) | 2.53368142 |
| 93 | Polydipsia (HP:0001959) | 2.53038172 |
| 94 | Abnormal drinking behavior (HP:0030082) | 2.53038172 |
| 95 | Hyperbilirubinemia (HP:0002904) | 2.52279836 |
| 96 | Abnormality of renin-angiotensin system (HP:0000847) | 2.51329487 |
| 97 | Vomiting (HP:0002013) | 2.49816092 |
| 98 | Tetany (HP:0001281) | 2.49346715 |
| 99 | Enlarged kidneys (HP:0000105) | 2.49129734 |
| 100 | Renal tubular acidosis (HP:0001947) | 2.48958775 |
| 101 | Hemorrhage of the eye (HP:0011885) | 2.47901554 |
| 102 | Renal salt wasting (HP:0000127) | 2.47002089 |
| 103 | Late onset (HP:0003584) | 2.42690763 |
| 104 | Hyperaldosteronism (HP:0000859) | 2.42600362 |
| 105 | Mitral stenosis (HP:0001718) | 2.40934178 |
| 106 | Spastic diplegia (HP:0001264) | 2.38528059 |
| 107 | Irritability (HP:0000737) | 2.36398591 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.32936844 |
| 109 | Sensorimotor neuropathy (HP:0007141) | 2.30007305 |
| 110 | Confusion (HP:0001289) | 2.29319297 |
| 111 | Abnormality of complement system (HP:0005339) | 2.27566830 |
| 112 | Abnormal urine phosphate concentration (HP:0012599) | 2.25532614 |
| 113 | Abnormality of the intrinsic pathway (HP:0010989) | 2.23680232 |
| 114 | Steatorrhea (HP:0002570) | 2.21839967 |
| 115 | Hypercholesterolemia (HP:0003124) | 2.21574609 |
| 116 | Neonatal onset (HP:0003623) | 2.19699406 |
| 117 | Hypophosphatemia (HP:0002148) | 2.16717628 |
| 118 | Hypercalciuria (HP:0002150) | 2.15862813 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.14754087 |
| 120 | Bone pain (HP:0002653) | 2.13453769 |
| 121 | Hypothermia (HP:0002045) | 2.10992343 |
| 122 | Chronic diarrhea (HP:0002028) | 2.10689650 |
| 123 | Esophageal varix (HP:0002040) | 2.08476534 |
| 124 | Abnormality of carpal bone ossification (HP:0006257) | 2.08202567 |
| 125 | Ileus (HP:0002595) | 2.04536385 |
| 126 | Abnormal pancreas size (HP:0012094) | 2.04428791 |
| 127 | Cerebral edema (HP:0002181) | 2.04014439 |
| 128 | Aortic aneurysm (HP:0004942) | 2.01813586 |
| 129 | Nausea (HP:0002018) | 1.98859128 |
| 130 | Dehydration (HP:0001944) | 1.98520553 |
| 131 | Abdominal distention (HP:0003270) | 1.97962384 |
| 132 | Pancreatitis (HP:0001733) | 1.97780774 |
| 133 | Abnormality of the nasal septum (HP:0000419) | 1.96596303 |
| 134 | Hypophosphatemic rickets (HP:0004912) | 1.96536998 |
| 135 | Abnormality of vitamin metabolism (HP:0100508) | 1.93565611 |
| 136 | Hypotension (HP:0002615) | 1.92464662 |
| 137 | Flat acetabular roof (HP:0003180) | 1.92311770 |
| 138 | Abnormal biliary tract morphology (HP:0012440) | 1.91827623 |
| 139 | Abnormal cortical bone morphology (HP:0003103) | 1.84768120 |
| 140 | Abnormal glucose tolerance (HP:0001952) | 1.84683149 |
| 141 | Bronchomalacia (HP:0002780) | 1.82650197 |
| 142 | Male infertility (HP:0003251) | 1.79238721 |
| 143 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.78683205 |
| 144 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73836995 |
| 145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73836995 |
| 146 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73836995 |
| 147 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72134806 |
| 148 | Mucopolysacchariduria (HP:0008155) | 1.72134806 |
| 149 | Abnormality of the right ventricle (HP:0001707) | 1.70493967 |
| 150 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.69875087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.82028031 |
| 2 | WNK3 | 5.27134615 |
| 3 | OXSR1 | 5.01185663 |
| 4 | BCKDK | 4.85421020 |
| 5 | MST1R | 3.17656686 |
| 6 | STK39 | 2.98820615 |
| 7 | FGFR4 | 2.83669281 |
| 8 | ERN1 | 2.77122588 |
| 9 | MAP3K12 | 2.69818384 |
| 10 | FRK | 2.68358479 |
| 11 | STK38L | 2.24673338 |
| 12 | STK24 | 2.06576777 |
| 13 | SIK1 | 1.92583759 |
| 14 | NME1 | 1.85863374 |
| 15 | ERBB4 | 1.78171769 |
| 16 | LMTK2 | 1.72377701 |
| 17 | PTK6 | 1.69826344 |
| 18 | EPHA2 | 1.64796067 |
| 19 | PDK4 | 1.46894467 |
| 20 | PDK3 | 1.46894467 |
| 21 | LATS1 | 1.45120942 |
| 22 | INSRR | 1.44118675 |
| 23 | PKN2 | 1.38764883 |
| 24 | TAOK3 | 1.33261466 |
| 25 | MST4 | 1.32279994 |
| 26 | TRIB3 | 1.31982642 |
| 27 | ACVR1B | 1.28079132 |
| 28 | MAPK11 | 1.27083055 |
| 29 | NEK1 | 1.24824615 |
| 30 | GRK6 | 1.19537153 |
| 31 | MET | 1.16105055 |
| 32 | MAP3K3 | 1.14231979 |
| 33 | RIPK1 | 1.10609493 |
| 34 | SGK223 | 1.09816533 |
| 35 | SGK494 | 1.09816533 |
| 36 | ILK | 1.08356783 |
| 37 | TNIK | 1.08200739 |
| 38 | NEK9 | 1.06658049 |
| 39 | MAP3K7 | 1.05908652 |
| 40 | PTK2 | 1.05450360 |
| 41 | EPHB1 | 1.03745691 |
| 42 | MAP2K2 | 0.98584881 |
| 43 | EPHA3 | 0.98526594 |
| 44 | MAP3K2 | 0.95748772 |
| 45 | PDK2 | 0.94239549 |
| 46 | GSK3A | 0.91099419 |
| 47 | PRKAA2 | 0.90530908 |
| 48 | ZAP70 | 0.90053820 |
| 49 | ABL2 | 0.89881673 |
| 50 | LRRK2 | 0.87400767 |
| 51 | STK38 | 0.82970840 |
| 52 | NLK | 0.82849898 |
| 53 | FER | 0.82148950 |
| 54 | MAP3K6 | 0.81737993 |
| 55 | DYRK1B | 0.81256229 |
| 56 | ERBB2 | 0.80963137 |
| 57 | SGK3 | 0.80203668 |
| 58 | PRKG2 | 0.78522331 |
| 59 | MAP2K4 | 0.77998173 |
| 60 | TGFBR2 | 0.77541847 |
| 61 | PIK3CG | 0.73266876 |
| 62 | DDR2 | 0.70264384 |
| 63 | PRKAA1 | 0.69554981 |
| 64 | WNK1 | 0.68503289 |
| 65 | ICK | 0.65084118 |
| 66 | PAK4 | 0.64351038 |
| 67 | MAPK15 | 0.64311859 |
| 68 | TYK2 | 0.64083936 |
| 69 | JAK2 | 0.63149805 |
| 70 | PDGFRB | 0.62101512 |
| 71 | FLT3 | 0.62061741 |
| 72 | CDC42BPA | 0.61194661 |
| 73 | MAP3K11 | 0.60740908 |
| 74 | MAP3K14 | 0.59920705 |
| 75 | MAP2K6 | 0.59725401 |
| 76 | PRKCZ | 0.58409312 |
| 77 | SGK2 | 0.57704667 |
| 78 | ROCK1 | 0.57549357 |
| 79 | MAP2K1 | 0.57291464 |
| 80 | TESK1 | 0.57251837 |
| 81 | PBK | 0.57224228 |
| 82 | PRKCE | 0.57145749 |
| 83 | PINK1 | 0.54356360 |
| 84 | IKBKE | 0.54092907 |
| 85 | FGFR2 | 0.53892319 |
| 86 | DAPK1 | 0.53689971 |
| 87 | CDK6 | 0.53488915 |
| 88 | PAK3 | 0.51874356 |
| 89 | MYLK | 0.51674996 |
| 90 | EPHB2 | 0.51105661 |
| 91 | KDR | 0.50955807 |
| 92 | MAP3K10 | 0.50901107 |
| 93 | PDPK1 | 0.49560239 |
| 94 | FGFR3 | 0.48391980 |
| 95 | TBK1 | 0.46468659 |
| 96 | CHUK | 0.46120550 |
| 97 | TIE1 | 0.45876985 |
| 98 | PRKACG | 0.45017523 |
| 99 | CAMK2G | 0.44248066 |
| 100 | PDGFRA | 0.43658723 |
| 101 | SRC | 0.43522446 |
| 102 | MAP2K3 | 0.42657070 |
| 103 | DAPK2 | 0.42557652 |
| 104 | IRAK3 | 0.39936103 |
| 105 | AKT3 | 0.38977585 |
| 106 | CDK9 | 0.36733501 |
| 107 | CSK | 0.36358705 |
| 108 | HIPK2 | 0.35929056 |
| 109 | STK10 | 0.35454028 |
| 110 | RPS6KA4 | 0.34309760 |
| 111 | MAP3K1 | 0.32122660 |
| 112 | MAPK4 | 0.31841537 |
| 113 | MELK | 0.31670807 |
| 114 | PRKD2 | 0.30436239 |
| 115 | MAP3K13 | 0.30111300 |
| 116 | JAK1 | 0.29255962 |
| 117 | DAPK3 | 0.28863046 |
| 118 | PRKD1 | 0.27376694 |
| 119 | RPS6KA2 | 0.27348056 |
| 120 | PDK1 | 0.26882763 |
| 121 | BMPR1B | 0.26834638 |
| 122 | DMPK | 0.26756894 |
| 123 | IKBKB | 0.26461054 |
| 124 | PRKCI | 0.26120180 |
| 125 | CSNK1G1 | 0.25201527 |
| 126 | PRKCQ | 0.24987254 |
| 127 | BMX | 0.24921459 |
| 128 | NUAK1 | 0.24620577 |
| 129 | SGK1 | 0.24443860 |
| 130 | PRKCA | 0.24253427 |
| 131 | GRK1 | 0.23298879 |
| 132 | PIK3CA | 0.22936027 |
| 133 | PRPF4B | 0.22619646 |
| 134 | AKT2 | 0.22590013 |
| 135 | MATK | 0.21633530 |
| 136 | ERBB3 | 0.21472557 |
| 137 | STK3 | 0.21402237 |
| 138 | VRK2 | 0.20882132 |
| 139 | IGF1R | 0.20650299 |
| 140 | CAMK2D | 0.20435125 |
| 141 | KSR2 | 0.19974331 |
| 142 | PRKCD | 0.18509010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.58999336 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.37737262 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11380770 |
| 4 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.97310829 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91910115 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.85269600 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72948828 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70354216 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.69876896 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.65243152 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64041321 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55890261 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.39500694 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35513204 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35249870 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.27767517 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.26807344 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07860085 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.98397999 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.91833913 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87198250 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.86683034 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84324048 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.83999843 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.80675504 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80539540 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80431146 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79493438 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75788974 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.62420110 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57475051 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57251607 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52057194 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46715738 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46227919 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.44876354 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44020537 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36301234 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36050523 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.34638882 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33170768 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32768250 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.30493075 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27987797 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24136724 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22941690 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21679141 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20107599 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12135584 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10510949 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10152458 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09948279 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03138676 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02752661 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 1.01790541 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98905328 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98417196 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96496134 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.93153457 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87589219 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86948283 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85590129 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76114717 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72516180 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71657136 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69271252 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64455281 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.63124811 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63115967 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55350670 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54712457 |
| 72 | * Tight junction_Homo sapiens_hsa04530 | 0.53676755 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51497349 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41744418 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.41618870 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39163748 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38886583 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38711669 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36123094 |
| 80 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35808374 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34094574 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33622420 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.33151608 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31405868 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.29995237 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29686576 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25812497 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23135905 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22028823 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21282877 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21152168 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20115562 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.19539905 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19240988 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18588435 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18480450 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.17923779 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17764202 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.17269807 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.16853087 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.16697302 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15237711 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14259361 |
| 104 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.13740740 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13489656 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12815537 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.07949832 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07448133 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04104031 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04086471 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03057156 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02010430 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | -0.2020999 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1966465 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1714755 |
| 116 | * Hepatitis C_Homo sapiens_hsa05160 | -0.1321039 |
| 117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0759846 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | -0.0269819 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0231849 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | -0.0221972 |
| 121 | Lysosome_Homo sapiens_hsa04142 | -0.0065735 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0024068 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0011243 |

